Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-28

Clinical Trial Update: Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether isosorbide mononitrate improves activity tolerance in heart failure with preserved ejection fraction; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Mononitrate (isosorbide mononitrate)

Snippet

Sponsor: Adrian Hernandez | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2016-11-28